Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

RAHWAY, NJ US

1. 20090275619 Amide Substituted Indazole and Benzotriazole Derivatives as Poly(ADP-Ribose)Polymerase (PARP) Inhibitors 11-05-2009
2. 20090275617 Aryl-Substituted Nitrogen-Containing Heterocyclic Compounds 11-05-2009
3. 20090275550 Pyridyl Amide T-Type Calcium Channel Antagonists 11-05-2009
4. 20090275515 2-HYDROXY-2-PHENYLTHIOPHENYLPROPIONAMIDES AS ANDROGEN RECEPTOR MODULATORS 11-05-2009
5. 20090270511 PRODRUGS OF INHIBITORS OF CATHEPSIN S - compounds of formula which are prodrugs of inhibitors of cathepsin S and as such are useful in the prevention 10-29-2009
6. 20090270477 POLYMORPHS OF A HYDROISOINDOLINE TACHYKININ RECEPTOR ANTAGONIST 10-29-2009
7. 20090270467 Aminocyclohexanes as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes 10-29-2009
8. 20090270451 Piperdine Glycine Transporter Inhibitors 10-29-2009
9. 20090270436 SPIROCHROMANON DERIVATIVES - compound of a general formula : wherein Ar1 represents a group formed from an aromatic ring selected from a group 10-29-2009
10. 20090270434 AZACYCLOALKANE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE 10-29-2009
11. 20090270406 Combination Therapy for the Treatment of Urinary Frequency, Urinary Urgency and Urinary Incontinence 10-29-2009
12. 20090270395 EP4 Receptor Agonist, Compositions and Methods Thereof 10-29-2009
13. 20090270351 PHOSPHORUS DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS 10-29-2009
14. 20090269278 Radiolabeled Glycine Trasporter Inhibitors 10-29-2009
15. 20090264622 Rhesus monkey Nur77 - The Macaca mulatta Nur77 nuclear receptor and the nucleic acid encoding the rhNur77 nuclear receptor are described 10-22-2009
16. 20090264479 Papain Family Cysteine Protease Inhibitors for the Treatment of Parasitic Diseases 10-22-2009
17. 20090264476 CB-1 receptor modulator formulations - Described herein are solid stable pharmaceutical formulations of cannabinoid receptor inverse agonists 10-22-2009
18. 20090264473 Novel Crystalline Forms of Antidiabetic Compounds 10-22-2009
19. 20090264436 CB-1 receptor modulator formulations - Described herein are solid stable pharmaceutical formulations of cannabinoid receptor inverse agonists 10-22-2009
20. 20090264426 Bicyclic aromatic substituted pyridone derivative 10-22-2009
21. 20090264405 Cetp Inhibitors - Compounds of Formula I including pharmaceutically acceptable salts of the compounds are CETP inhibitors 10-22-2009
22. 20090258918 EP4 receptor agonist, compositions and methods thereof 10-15-2009
23. 20090258913 Triazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1 10-15-2009
24. 20090258903 Aminoethane Sulfonamide Orexin Receptor Antagonists 10-15-2009
25. 20090258894 Fused Aminopiperidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes 10-15-2009
26. 20090258891 Macrocyclic Compounds As Antiviral Agents 10-15-2009
27. 20090258885 Diphenylmethane Derivatives as Inhibitors of Leukotriene Biosynthesis 10-15-2009
28. 20090258884 Substituted amides - Novel compounds of the structural formula are antagonists and/or inverse agonists of the Cannabinoid-1 receptor and are useful in 10-15-2009
29. 20090258871 Aza-Substituted Spiro Derivatives - compound of the following formula or its pharmaceutically-acceptable salt is provided: STR00001 [wherein X 10-15-2009
30. 20090258862 Niacin receptor agonists, compositions containing such compounds and methods of treatment 10-15-2009
31. 20090258853 Somatostatin Agonists - This invention relates to compounds which are agonists of somatostatin and selective toward somatostatin receptor subtype SSTR2 10-15-2009
32. 20090258852 Inhibitors of Checkpoint Kinases - The instant invention provides for compounds which comprise benzoisoquinolinones and aza derivatives that inhibit 10-15-2009
33. 20090258851 DIARYL SUBSTITUTED ALKANES - The instant invention provides compounds of Formula II which are 5-lipoxygenase activating protein inhibitors 10-15-2009
34. 20090253769 Inhibitors of mammalian hdac 11 useful for treating hdac 11 mediated disorders 10-08-2009
35. 20090253756 Indole Amide Derivatives as EP4 Receptor Antagonists 10-08-2009
36. 20090253744 Acylated piperidine derivatives as melanocortin-4 receptor modulators 10-08-2009
37. 20090253734 INHIBITORS OF AKT ACTIVITY - The instant invention provides for substituted naphthyridine compounds that inhibit Akt activity 10-08-2009
38. 20090253705 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS 10-08-2009
39. 20090253681 HIV Integrase Inhibitors - Compounds of Formula I are inhibitors of FHV integrase and inhibitors of FHV replication , wherein m, n, X, R 10-08-2009
40. 20090253673 Substituted Pyrazoles as Ghrelin Receptor Antagonists 10-08-2009
41. 20090253672 Cathepsin Cysteine Protease Inhibitors - This invention relates to a novel class of compounds represented by the formula below wherein the meanings of 10-08-2009
42. 20090253665 METHOD OF TREATMENT OF DISEASE USING AN ADENOSINE A1 RECEPTOR ANTAGONIST AND AN ALDOSTERONE INHIBITOR 10-08-2009
43. 20090247770 PROCESS FOR MAKING LACTAM TACHYKININ RECEPTOR ANTAGONISTS 10-01-2009
44. 20090247596 THIOPHENECARBOXAMIDE DERIVATIVES AS EP4 RECEPTOR LIGANDS 10-01-2009
45. 20090247565 Tyrosine Kinase Inhibitors - imidazo[1 2-a]pyrimidine derivatives that are useful for treating cellular proliferative diseases 10-01-2009
46. 20090247560 Diaryl ketimine derivative - Provided is a compound of a formula : STR00001 [wherein R 10-01-2009
47. 20090247549 Methods of using saha and bortezomib for treating cancer 10-01-2009
48. 20090247514 Spirolactam aryl cgrp receptor antagonists 10-01-2009
49. 20090247504 Indazole Derivatives for Treatment of Alzheimer's Disease 10-01-2009
50. 20090247499 SULFONYLATED PIPERAZINES AS CANNABINOID-1 RECEPTOR MODULATORS 10-01-2009
51. 20090247460 Inhibitor of vascular endothelial cell growth factor 10-01-2009
52. 20090246192 1D05 PCSK9 antagonists - Antagonists of human proprotein convertase subtilisin-kexin type 9 are disclosed 10-01-2009
53. 20090239946 Pharmaceutical compositions of HDAC inhibitors and chelatable metal compounds, and metal-HDAC inhibitors chelate complexes 09-24-2009
54. 20090239905 PIPERIDINES AND RELATED COMPOUNDS FOR THE TREATMENT OF DEMENTIA 09-24-2009
55. 20090239876 Substituted 4-Hydroxypyrimidine-5-Carboxamides 09-24-2009
56. 20090239870 Spirohydantoin Aryl Cgrp Receptor Antagonists 09-24-2009
57. 20090239862 Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators 09-24-2009
58. 20090239849 Aryl-Fused Spirocyclic Compounds - novel class of aryl-fused spirocyclic compounds 09-24-2009
59. 20090239843 Bridged diazepan orexin receptor antagonists 09-24-2009
60. 20090233992 HEPATITIS C VIRUS VACCINE - The present invention features Ad6 vectors and a nucleic acid encoding a Met-NS3-NS4A-NS4B-NS5A-NS5B polypeptide containing 09-17-2009
61. 20090233936 Fused Aminopiperidines as Dipeptidyl Peptidase-4 Inhibitors for the Treatment or Prevention of Diabetes 09-17-2009
62. 20090233896 Inhibitors of checkpoint kinases - The instant invention provides for compounds which comprise substituted pyridyl aminothiazoles that inhibit CHK1 09-17-2009
63. 20090232795 1B20 PCSK9 ANTAGONISTS - Antagonists of human proprotein convertase subtilisin-kexin type 9 are disclosed 09-17-2009
64. 20090221679 Novel HIV Targets - Using a method to measure the effect of downregulation of certain cellular proteins on HIV integration 09-03-2009
65. 20090221669 Disubstituted Aniline Compounds - novel class of disubstituted aniline compounds 09-03-2009
66. 20090221611 Fused Triazole Tachykinin Receptor Antagonists 09-03-2009
67. 20090221592 Dodecylsulfate Salt Of A Dipeptidyl Peptidase-Iv Inhibitor 09-03-2009
68. 20090221571 HIV INTEGRASE INHIBITORS - Pyridopyrimidine carboxamide compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: 09-03-2009
69. 20090221535 IMMUNOGENIC COMPOSITIONS FOR GRAM POSITIVE BACTERIA SUCH AS STREPTOCOCCUS AGALACTIAE 09-03-2009
70. 20090215825 SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE 08-27-2009
71. 20090215775 Sulphonamido-Substituted Cyclohexyl Sulphones for Treatment of Cancer 08-27-2009
72. 20090215101 HCV Protease substrates - The present invention features HCV NS3 protease substrates containing a europium label and a quenching group 08-27-2009
73. 20090209571 Phenanthrene derivatives as MPGES-1 inhibitors 08-20-2009
74. 20090209566 Spirocyclic Compounds - novel class of substituted spirocyclic compounds represented by the following structural Formula: I Wherein A 08-20-2009
75. 20090209564 Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use 08-20-2009
76. 20090209562 Fused ring 4-oxopyrimidine derivative - compound represented by formula below or a pharmaceutically acceptable salt thereof 08-20-2009
77. 20090209556 SOLUBLE GUANYLATE CYCLASE ACTIVATORS - compound having the structure STR00001 useful for treatment or prevention of cardiovascular diseases 08-20-2009
78. 20090209544 Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes 08-20-2009
79. 20090209523 Pyrrolo[1,2-A] Pyrazin-1(2H)-One and Pyrrolo[1,2-D][1,2,4]Triazin-1(2H)-One Derivatives as Inhibitors of Poly(Adp-Ribose)Polymerase (Parp) 08-20-2009
80. 20090209024 Combinatorial DNA library for producing modified N-glycans in lower eukaryotes 08-20-2009
81. 20090203922 Process for Synthesizing 2-Phenyl-1H-Phenanthro[9,10-d]Imidazole Derivative 08-13-2009
82. 20090203903 Thiazolyl mglur5 antagonists and methods for their use 08-13-2009
83. 20090203710 Novel piperidine derivative - Provided are a histamine-H3 receptor antagonist 08-13-2009
84. 20090203684 Tyrosine kinase inhibitors - 5H-benzo[4 5]cyclohepta[1 2-b]pyridine derivatives of formula that are useful for treating cellular proliferative diseases 08-13-2009
85. 20090203105 URA5 gene and methods for stable genetic integration in yeast 08-13-2009
86. 20090203008 Rapid method to determine inhibitor sensitivity of NS3/4A protease sequences cloned from clinical samples 08-13-2009
87. 20090202987 Canis sphingosine 1-phosphate receptor isoform 2 08-13-2009
88. 20090197908 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met 08-06-2009
89. 20090197904 Sulphamides for Treatment of Cancer - Bridged bicyclic sulphamides of formula are disclosed for treatment of cancer 08-06-2009
90. 20090197900 METHODS OF TREATING HEART FAILURE AND RENAL DYSFUNCTION IN INDIVIDUALS WITH AN ADENOSINE A1 RECEPTOR ANTAGONIST 08-06-2009
91. 20090197883 Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use 08-06-2009
92. 20090197299 Method for Assessing Airborn Microorganisms 08-06-2009
93. 20090192174 Novel Aminopyridine Derivatives Having Aurora a Selective Inhibitory Action 07-30-2009
94. 20090192158 Methods for Treating or Preventing Neoplasias 07-30-2009
95. 20090192155 Identification of Compounds Suitable for Treating Ad 07-30-2009
96. 20090192143 Substituted diazepan orexin receptor antagonists 07-30-2009
97. 20090192139 CGRP RECEPTOR ANTAGONISTS - compounds of Formula I: STR00001 and Formula II: STR00002 useful as antagonists of CGRP receptors and useful in the 07-30-2009
98. 20090191578 Canis sphingosine 1-phosphate receptor isoform 5 07-30-2009
99. 20090191552 Novel Human Acidic Mammalian Chitinase and Use Thereof 07-30-2009
100. 20090187028 Process for preparing Chiral Dipeptidyl Peptidase -IV Inhibitor Intermediates 07-23-2009
101. 20090186928 Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1 07-23-2009
102. 20090186926 Self-Emulsifying Formulations of CETP Inhibitors 07-23-2009
103. 20090186919 PIPERIDINE DERIVATIVES FOR TREATMENT OF ALZHEIMER'S DISEASE 07-23-2009
104. 20090186871 Tyrosine kinase inhibitors - compounds that are capable of inhibiting modulating and/or regulating signal transduction of both receptor-type and 07-23-2009
105. 20090182021 Tricyclic Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease 07-16-2009
106. 20090182002 Tyrosine kinase inhibitors - This invention relates to salt forms of the compound N-[-1 4-dioxan-2-ylmethyl]-N-methyl-N'-[3--- 5-oxo-5H-benzo[4 07-16-2009
107. 20090182001 Inhibitors of checkpoint kinases - The instant invention provides for compounds which comprise fused imidazoles that inhibit CHK1 activity 07-16-2009
108. 20090181994 TRIAZOLE DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE-1 07-16-2009
109. 20090181946 Benzaepinones as Sodium Channel Blockers 07-16-2009
110. 20090176986 Process for the Preparation of Pyridine Heterocycle Cgrp Antagonist Intermediate 07-09-2009
111. 20090176861 Cathepsin cysteine protease inhibitors - novel class of compounds mainly substituted leucinamide-carboxylate derivatives of formula wherein X is O or NR 07-09-2009
112. 20090176859 Cathepsin cysteine protease inhibitors - novel class of compounds mainly, leucinamide-amino-carboxylate derivatives of formula wherein Y is CR 07-09-2009
113. 20090176854 PYRAZOLE DERIVATIVES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE 07-09-2009
114. 20090176836 Cyclic Ketal Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease 07-09-2009
115. 20090176789 Diazaspirodecane orexin receptor antagonists 07-09-2009
116. 20090176765 Pyridinone and Pyridazinone Derivatives as Inhibitors of Poly (Adp-Ribose) Polymerase (Parp) 07-09-2009
117. 20090176757 Bicyclic Spirohydantoin CGRP Receptor Antagonists 07-09-2009
118. 20090176263 Canis sphingosine 1-phosphate receptort isoform 1 07-09-2009
119. 20090176243 Novel monkey GPR103 and monkey QRFP and method of evaluating compound by using GPR103 07-09-2009
120. 20090170891 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment 07-02-2009
121. 20090170863 Acylated Spiropiperidine Derivatives as Melanocortin-4 Receptor Modulators 07-02-2009
122. 20090170830 Tricyclic Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease 07-02-2009
123. 20090170828 Azetidine Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase 07-02-2009
124. 20090170824 Diarylsulfones as 5-HT2A Antagonists - Compounds of formula I: STR00001 are potent and selective antagonists of the human 5-HT 07-02-2009
125. 20090170159 PRODUCTION OF GLYCOPROTEINS WITH REDUCED O-GLYCOSYLATION 07-02-2009
126. 20090163559 Estrogen receptor modulators - compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators 06-25-2009
127. 20090163544 Use of NK-3 Receptor Antagonists for the Treatment of Nausea and Vomiting 06-25-2009
128. 20090163379 Eukaryotic cell display systems - expression vectors and helper display vectors which can be used in various combinations as vector sets for display of 06-25-2009
129. 20090162377 Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoform 06-25-2009
130. 20090156825 Fluorescent compounds that bind to histone deacetylase 06-18-2009
131. 20090156619 Heterocycle Substituted Amide and Sulfur Amide Derivatives as Histone Deacetylase (HDAC) Inhibitors 06-18-2009
132. 20090156617 Tyrosine kinase inhibitors - imidazo[1 2-a]pyrimidine derivatives that are useful for treating cellular proliferative diseases 06-18-2009
133. 20090156591 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors 06-18-2009
134. 20090156579 Combination of a Dipeptidyl Peptidase-4 Inhibitor and an Anti-Hypertensive Agent for the Treatment of Diabetes and Hypertension 06-18-2009
135. 20090155847 Combinatorial DNA library for producing modified N-glycans in lower eukaryotes 06-18-2009
136. 20090155298 Matrix Metalloproteinase 11 Vaccine - Compositions comprising matrix metalloproteinase 11 or stromelysin-3 or the nucleic acid en-> 06-18-2009
137. 20090149526 Tetracyclic Indole Derivatives as Antiviral Agents 06-11-2009
138. 20090149470 Novel aminopyridine derivatives having aurora a selective inhibitory action 06-11-2009
139. 20090149467 Tyrosine Kinase Inhibitors - pyridinyloxy- and pyrimidinyloxyindole derivatives that are useful for treating cellular proliferative diseases 06-11-2009
140. 20090149398 6,11-3c-bicyclic 8a-azalide derivatives - Compounds of Formula , and pharmaceutically acceptable salts, esters, and prodrugs thereof: are disclosed, 06-11-2009
141. 20090148850 Methods for identifying modulators of P2RY14 06-11-2009
142. 20090143429 Quinoline Derivatives as Neurokinin Receptor Antagonists 06-04-2009
143. 20090143413 Thiazole Derivatives as CXCR3 Receptor Modulators 06-04-2009
144. 20090137587 Phenylpyridone Derivative - compound represented by the formula is contained as an active ingredient: STR00001 wherein R 05-28-2009
145. 20090137576 Novel Piperidine Derivative - substance having an antagonistic effect on the binding of histamine to a histamine H3 receptor or an inhibitory effect on 05-28-2009
146. 20090137548 1,3-Oxazolidin-2-One Derivatives Useful as Cetp Inhibitors 05-28-2009
147. 20090137546 Anti-Hypercholesterolemic Compounds - This invention provides cholesterol absorption inhibitors of Formula I: and the pharmaceutically acceptable salts 05-28-2009
148. 20090137529 SUBSTITUTED ESTERS AS CANNABINOID-1 RECEPTOR MODULATORS 05-28-2009
149. 20090136979 Class IIA Histone Deacetylase (HDAC) Substrate 05-28-2009
150. 20090136957 Methods and compositions for regulating cell cycle progression via the miR-106B family 05-28-2009
151. 20090136570 Taste-Masked Tablets and Granules - Orally administered taste-masked tablets and granules contain a hydroxypyrimidinone carboxamide a 05-28-2009
152. 20090136525 Immunoglobulins Comprising Predominantly a Glcnacman3Glcnac2 Glycoform 05-28-2009
153. 20090136449 Tetracyclic Indole Derivatives as Antiviral Agents 05-28-2009
154. 20090131664 Method for Producing 4(3H)-Quinazolinone Derivative 05-21-2009
155. 20090131494 Non-Nucleoside Reverse Transcriptase Inhibitors 05-21-2009
156. 20090131472 P38 Kinase Inhibiting Agents - Compounds described by the chemical formula or pharmaceutically acceptable salts thereof: are inhibitors of p38 and are 05-21-2009
157. 20090131465 Synthesis and crystalline forms of melanocortin-4 receptor agonist 05-21-2009
158. 20090131464 SPIROCHROMANONE DERIVATIVES AS ACETYL COENZYME A CARBOXYLASE (ACC) INHIBITORS 05-21-2009
159. 20090131451 Diagnosis and treatment of type 2 diabetes and other disorders 05-21-2009
160. 20090131423 Tyrosine Kinase Inhibitors - imidazo[1 2-a]pyrimidine derivatives that are useful for treating cellular proliferative diseases 05-21-2009
161. 20090131419 Sulphones which modulate the action of gamma secretase 05-21-2009
162. 20090130709 Endomannosidases in the modification of glycoproteins in eukaryotes 05-21-2009
163. 20090124799 Process for the preparation of Caprolactam Cgrp Antagonist 05-14-2009
164. 20090124689 CETP Inhibitors - Compounds having a biphenyl group substituted with a phenyl or heteroaromatic group as shown in Formula I 05-14-2009
165. 20090124665 Potassium Channel Inhibitors - compounds having the structure useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like 05-14-2009
166. 20090124661 HCV NS3 PROTEASE INHIBITORS - macrocyclic compounds of formula that are useful as inhibitors of the hepatitis C virus NS3 protease 05-14-2009
167. 20090124648 Synthesis and Crystalline Forms of Npy5 Antagonist 05-14-2009
168. 20090124641 Mitotic Kinesin Inhibitors - fluorinated 2-aminomethylquinazolinone derivatives that are useful for treating cellular proliferative diseases 05-14-2009
169. 20090124603 Diazepan Orexin Receptor Antagonists - diazepan compounds which are antagonists of orexin receptors 05-14-2009
170. 20090124601 Tartaric Acid Salts of a Dipeptidyl Peptidase-IV Inhibitor 05-14-2009
171. 20090124600 N-Alkyl-Azacycloalkyl NMDA/NR2B Antagonists 05-14-2009
172. 20090124000 Recombinant Vectors - Methods and materials are provided for integrating heterologous nucleic acids into the genome of a cell or virus without 05-14-2009
173. 20090123571 Method of treating men with testosterone supplement and 5alpha-reductase inhibitor 05-14-2009
174. 20090123538 Angiotensin II Receptor Antagonists - The compounds of the present invention are polymorphic crystalline forms of the compound 05-14-2009
175. 20090118304 2-HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE 05-07-2009
176. 20090118300 Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators 05-07-2009
177. 20090118296 Heteroaromatic Compounds As Inhibitors Of Stearoyl-Coenzyme A Delta-9 Desaturase 05-07-2009
178. 20090118291 Histone deacetylase inhibitors - This invention relates to hydroxamic acid derivatives having a carbamate linkage that are inhibitors of histone 05-07-2009
179. 20090118223 Novel 2'-c-methyl and 4'c-methyl nucleoside derivatives 05-07-2009
180. 20090118200 Proline bis-amide orexin receptor antagonists 05-07-2009
181. 20090117616 Methods for reducing or eliminating alpha-mannosidase resistant glycans for the production of glycoproteins 05-07-2009
182. 20090117590 Human calcium sensitive potassium channel beta3 subunit proteins, encoding nucleic acid and uses thereof 05-07-2009
183. 20090111997 Method of Generating Amorphous Solid for Water-Insoluble Pharmaceuticals 04-30-2009
184. 20090111832 Imidazolidinone Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease 04-30-2009
185. 20090105479 4-Oxo-1-3-Substituted Phenyl-1,4-Dihydro-1,8-Napthyridene-3-Carboxamide Phosphodiesterase-4 Inhibitor and a Method of Preparing Same 04-23-2009
186. 20090105321 Indole Amide Derivatives as Ep4 Receptot Ligands 04-23-2009
187. 20090105318 Amidoethylthioether Orexin Receptor Antagonists 04-23-2009
188. 20090105310 Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use 04-23-2009
189. 20090105284 Aminocyclohexanes as Dipeptidyl Peptidase-IV for the Treatment or Prevention of Diabetes 04-23-2009
190. 20090105270 Kinase inhibition and anticancer therapy 04-23-2009
191. 20090105265 Pharmaceutical Compositions of Combinations of Dipeptidyl Peptidase-4 Inhibitors With Metformin 04-23-2009
192. 20090105264 Substituted Nicotinamide Compounds - novel class of substituted nicotinamides 04-23-2009
193. 20090105234 EP4 Receptor Agonist, Compositions and Methods Thereof 04-23-2009
194. 20090105228 Heterocyclic benzodiazepine cgrp receptor antagonists 04-23-2009
195. 20090105227 Thienopyrroles As Antiviral Agents - tetracyclic thienopyrrole compounds of formula wherein Ar A 04-23-2009
196. 20090105219 Spirolactam Tricyclic CGRP Receptor Antagonists 04-23-2009
197. 20090105210 Bicyclic Pyrimidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes 04-23-2009
198. 20090105136 NPY Y2 Agonist for Use as Therapeutic Agent for Disease Accompanied by Diarrhea 04-23-2009
199. 20090104220 Method to Make a Peptide-Carrier Conjugate with a High Immunogenicity 04-23-2009
200. 20090104210 Peptide compounds for treating obesity and insulin resistance 04-23-2009
201. 20090099264 Fluoroalkylamine Derivatives as Cathepsin Inhibtors 04-16-2009
202. 20090099226 Quinoline derivatives as ep4 antagonists 04-16-2009
203. 20090099200 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase 04-16-2009
204. 20090099168 HIV Integrase inhibitors - Pyridopyrazine- and pyrimidopyrazine-dione compounds are inhibitors of HIV integrase and inhibitors of HIV replication 04-16-2009
205. 20090099126 Ribonucleoside Cyclic Acetal Derivatives for the Treatment of RNA-Dependent RNA Viral Infection 04-16-2009
206. 20090098604 Synthetic gene encoding human epidermal growth factor 2/NEU antigen and uses thereof 04-16-2009
207. 20090098155 Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease 04-16-2009
208. 20090093552 Addition of lecithin as an antistatic agent for the crystallization processing of organic molecules 04-09-2009
209. 20090093527 Azacyclopentane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase 04-09-2009
210. 20090093444 Cathepsin Cysteine Protease Inhibitors - This invention relates to a novel class of compounds which are cysteine protease inhibitors including but not 04-09-2009
211. 20090093020 Methods for reducing or eliminating alpha-mannosidase resistant glycans in the production of glycoproteins 04-09-2009
212. 20090092971 Method for Detecting p53 Dysfunction, Method for Molecular Diagnosis of Cancer and Method for Evaluating Compound Effective in Treating Cancer 04-09-2009
213. 20090089889 Neuromedin u receptor subtype 1 deficient transgenic mice and uses thereof 04-02-2009
214. 20090088477 Compounds and methods for leukotriene biosynthesis inhibition 04-02-2009
215. 20090088458 N-(Pyridin-4-Yl)-2-Phenylbutanamides as Androgen Receptor Modulators 04-02-2009
216. 20090088452 Indole Orexin Receptor Antagonists - substituted indole compounds which are antagonists of orexin receptors 04-02-2009
217. 20090088436 P38 Kinase Inhibiting Agents - Compounds described by the chemical formula or pharmaceutically acceptable salts thereof: STR00001 are inhibitors of p38 04-02-2009
218. 20090088431 Heteroaromatic Compounds as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase 04-02-2009
219. 20090082320 Fluorinated 4-azasteroid derivatives as androgen receptor modulators 03-26-2009
220. 20090082308 Benzothiophene derivatives - novel class of benzothiophene amide derivatives 03-26-2009
221. 20090082221 Cross-Species and Multi-Species Display Systems 03-26-2009
222. 20090081681 Method For Genetic Selection Of High-Plasmid Producing E. Coli Clones 03-26-2009
223. 20090081645 METHOD OF ASSUMING DRUG SENSITIVITY TO CDK4 INHIBITOR 03-26-2009
224. 20090076101 Thiophene and Thiazole Substituted Trifluoroethanone Derivatives as Histone Deacetylase (HDAC) Inhibitors 03-19-2009
225. 20090075998 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors 03-19-2009
226. 20090075979 CETP Inhibitors - Compounds having the structure of Formula including pharmaceutically acceptable salts of the compounds 03-19-2009
227. 20090075869 HCV NS3 protease inhibitors - macrocyclic compounds of formula that are useful as inhibitors of the hepatitis C virus NS3 protease 03-19-2009
228. 20090075319 Method of Detecting Reactive Metabolite - method of detecting a reactive metabolite which comprises steps of conducting a metabolic reaction of a test 03-19-2009
229. 20090074890 Substituted Triazoles as Sodium Channel Blockers 03-19-2009
230. 20090069391 Benzothiophene hydroxamic acid derivatives 03-12-2009
231. 20090069385 Antidiabetic Oxazolidinediones and Thiazolidinediones 03-12-2009
232. 20090069376 VLA-4 Antagonists - Substituted N--[N-sulfonyl-prolyl]-phenylalanine derivatives of the present invention are antagonists of the VLA-4 integrin and are 03-12-2009
233. 20090069344 Modulators of hcv replication - compounds of formula : STR00001 where X, Y, R 03-12-2009
234. 20090069312 Potassium Channel Inhibitors - dipyridin-3-ylmethoxy compounds and derivatives thereof having the structure I useful as potassium channel inhibitors to 03-12-2009
235. 20090069284 Substituted 3-alkyl and 3-alkenyl azetidine derivatives 03-12-2009
236. 20090069283 Potassium Channel Inhibitors - pyridine substituted ethanol compounds and derivatives thereof having the structure useful as potassium channel 03-12-2009
237. 20090069250 Inhibitors of Histone Deacetylase - novel class of compounds 03-12-2009
238. 20090068678 Method for identifying modulators of NOAH10 useful for treating Alzheimer's disease 03-12-2009
239. 20090062349 1-Hydroxycycloalkanecarboxamide derivatives 03-05-2009
240. 20090062327 Inhibitors of AKT Activity - The instant invention provides for compounds that inhibit Akt activity 03-05-2009
241. 20090062302 Jak2 Tyrosine Kinase Inhibition - methods for inhibiting JAK2 tyrosine kinase 03-05-2009
242. 20090062297 Hydroxyalkylarylamide Derivatives - novel class of hydroxyalkylarylamide derivatives 03-05-2009
243. 20090062293 1,4-Substituted Piperazine Derivatives - compound represented by the formula : STR00001 or a pharmaceutically acceptable salt thereof, wherein: R 03-05-2009
244. 20090062280 Ophthalmic Compositions for Treating Ocular Hypertension 03-05-2009
245. 20090062269 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment 03-05-2009
246. 20090054662 Process for synthesizing a substituted pyrazole 02-26-2009
247. 20090054506 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use 02-26-2009
248. 20090054483 Substituted Quinolines as Inhibitors of Leukotriene Biosynthesis 02-26-2009
249. 20090054462 Hydroisoindoline tachykinin receptor antagonists 02-26-2009
250. 20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors 02-26-2009
251. 20090054440 Quinoline derivatives as neurokinin receptor antagonists 02-26-2009
252. 20090054423 Niacin receptor agonists, compositions containing such compounds and methods of treatment 02-26-2009
253. 20090054408 Monocyclic anilide spirolactam cgrp receptor antagonists 02-26-2009
254. 20090054399 HIV INTEGRASE INHIBITORS - Tricyclic compounds of Formula are inhibitors of HIV integrase and inhibitors of HIV replication: wherein bond a, ring A, R 02-26-2009
255. 20090048308 VLA-4 Antagonists - 4-Thio 4-sulfinyl and 4-sulfonyl proline derivatives of the present invention are antagonists of the VLA-4 integrin and are useful 02-19-2009
256. 20090048283 Salt of an androgen receptor modulator - The biphthalate salts of compound I are modulators of the androgen receptor in a tissue selective manner 02-19-2009
257. 20090048276 Inhibitors of Fatty Acid Synthase (Fas) - The instant invention provides for compounds which comprise substituted 3-aryl-4-hydroxyquinolin-2-ones that 02-19-2009
258. 20090048248 Octahydropyrano[3,4-C]Pyrrole Tachykinin Receptor Antagonists 02-19-2009
259. 20090048239 Therapeutic compounds - class of macrocyclic compounds of formula , wherein R 02-19-2009
260. 20090048228 Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors 02-19-2009
261. 20090048227 Substituted-1-Phthalazinamines As Vr- 1 Antagonists 02-19-2009
262. 20090047702 Method for Identifying Modulators of Keah6 Useful for Treating Alzheimer's Disease 02-19-2009
263. 20090047303 Method for improving the immunogenicity of plasmodium antigens 02-19-2009
264. 20090042966 Mitotic Kinesin Inhibitors - fluorinated dihydropyrazole compounds that are useful for treating cellular proliferative diseases 02-12-2009
265. 20090042954 2-(Aryl)Azacyclylmethyl Carboxylates, Sulfonates, Phosphonates, Phosphinates and Heterocycles as S1p Receptor Antagonists 02-12-2009
266. 20090042944 Potassium Channel Inhibitors - compounds having the structure useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like 02-12-2009
267. 20090042926 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment 02-12-2009
268. 20090042892 Cetp Inhibitors - Compounds having the structure of Formula including pharmaceutically acceptable salts of the compounds 02-12-2009
269. 20090042854 Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor Antagonists 02-12-2009
270. 20090036503 Triazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1 02-05-2009
271. 20090036443 Thienopyrroles as antiviral agents - thienopyrrole compounds of formula 02-05-2009
272. 20090035277 Hepatitis C Virus Nucleic Acid Vaccine - The present invention features nucleic acid constructs that can be used as a HCV nucleic acid vaccine 02-05-2009
273. 20090030048 Novel pharmaceutical compounds - The instant invention provides compounds of Formula Ia which are leukotriene biosynthesis inhibitors 01-29-2009
274. 20090030043 Potassium Channel Inhibitors - tetraaryl methyl amine compounds and derivatives thereof having the structure useful as potassium channel inhibitors to 01-29-2009
275. 20090030012 Pyridine, Pyrimidine and Pyrazine Derivatives as Cxcr3 Receptor Modulators 01-29-2009
276. 20090029406 Npy Y4 Agonist as Therapeutic Agent for Disease Accompanied by Intestinal Tract Dysfunction 01-29-2009
277. 20090025095 Method for Evaluating Compound Using Barlp and Substance for Regulating Eating and Body Weight 01-22-2009
278. 20090023774 Pyridine analogs as C5A antagonists - novel compounds of Formula I which are antagonists of the C5a receptor 01-22-2009
279. 20090023767 Inhibitors of Checkpoint Kinases - The instant invention provides for compounds which comprise fused pyrazoles that inhibit CHK1 activity 01-22-2009
280. 20090023163 Method of Measuring Enzyme Activity and Method of Evaluating Compound 01-22-2009
281. 20090018340 Formation of Tetra-Substituted Enamides and Stereoselective Reduction Thereof 01-15-2009
282. 20090018056 Heteroarylcarbamoylbenzene derivatives 01-15-2009
283. 20090018054 Cholesteryl Ester Transfer Protein Inhibitors 01-15-2009
284. 20090017468 METHOD OF SCREENING COMPOUND DIRECTLY ACTIVATING GLYCOGEN SYNTHASE 01-15-2009
285. 20090012134 Arylsulfonyl Benzofused Heterocycles as 5-Ht2a Antagonists 01-08-2009
286. 20090012076 Tyrosine kinase inhibitors - 5H-benzo[4 5]cyclohepta[1 2-b]pyridine derivatives 01-08-2009
287. 20090012075 Fluorinated Arylamide Derivatives - novel class of fluorinated arylamide derivatives 01-08-2009
288. 20090012061 A Method of Treating Cancer - method of treating cellular proliferative diseases in particular cancer 01-08-2009
289. 20090007283 Transgenic Rodents Selectively Expressing Human B1 Bradykinin Receptor Protein 01-01-2009
290. 20090005418 Mitotic Kinesin Inhibitors - dihydroisoxazoles that are useful for treating cellular proliferative diseases 01-01-2009
291. 20090005389 2,5 Diaza-Bicyclo [2.2.1] Heptane Derivatives as Calcium Channel Blockers 01-01-2009
292. 20090005323 Cathepsin K Inhibitors and Obesity - This invention relates to the treatment of obesity the treatment of obesity related disorders prevention of weight 01-01-2009
293. 20080318976 Alpha-Hydroxy Amides as Bradykinin Antagonists or Inverse Agonists 12-25-2008
294. 20080318930 Sulfonyl Compound as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1 12-25-2008
295. 20080318927 Substituted monocyclic CGRP receptor antagonists 12-25-2008
296. 20080318310 Method and Apparatus for Automatically Isolating Microbial Species 12-25-2008
297. 20080312286 Indanone Potentiators of Metabotropic Glutamate Receptors 12-18-2008
298. 20080312274 Quinoline Derivatives as Neurokinin Receptor Antagonists 12-18-2008
299. 20080311137 Carcinoembryonic Antigen Fusions and Uses Thereof 12-18-2008
300. 20080306139 Antibiotic Compounds - Fermentation of a nutrient medium with a eubacterium Streptomyces sp 12-11-2008
301. 20080305081 Novel aminopyrimidine derivatives as PLK1 inhibitors 12-11-2008
302. 20080300261 Arylacetic Acids and Related Compounds for Treatment of Alzheimer's Disease 12-04-2008
303. 20080299616 Malate Synthase Regulatory Sequences for Heterologous Gene Expression in Pichia 12-04-2008
304. 20080293684 Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors 11-27-2008
305. 20080287523 Pyrrolidin-3-Yl Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease 11-20-2008
306. 20080287489 Ophthalmic compositions for treating ocular hypertension 11-20-2008
307. 20080287457 Inhibitors of Akt Activity - compounds which contain substituted naphthyridines which inhibit the activity of Akt 11-20-2008
308. 20080287414 Mitotic Kinesin Inhibitors - tricyclic pyrazoles according to Formula that are useful for treating cellular proliferative diseases 11-20-2008
309. 20080287394 Hiv Integrase Inhibitors - Hydroxy-substituted pyrazinopyrrolopyridazine dione compounds are inhibitors of HIV integrase and inhibitors of HIV 11-20-2008
310. 20080286275 Antigen Binding Proteins Directed Against Scavenger Receptor B1 that Inhibit Hcv Replication 11-20-2008
311. 20080280966 Hydroisoindoline Tachykinin Receptor Antagonists 11-13-2008
312. 20080280956 Heteroarylsulfonyl Stilbenes as 5-Ht2a Antagonists 11-13-2008
313. 20080280945 Crystalline forms of an HIV integrase inhibitor 11-13-2008
314. 20080280902 Inhibitors of Checkpoint Kinases - The instant invention provides for compounds which comprise substituted quinolinones that inhibit CHK1 activity 11-13-2008
315. 20080280899 Inhibitors of Akt Activity - compounds which contain substituted napthyridines which inhibit the activity of Akt 11-13-2008
316. 20080280889 Inhibitors of Akt Activity - compounds which contain substituted pyridazines and pyrimidines moieties which inhibit the activity of Akt 11-13-2008
317. 20080280873 Biaryl Substituted Pyrazinones as Sodium Channel Blockers 11-13-2008
318. 20080280857 CGRP receptor antagonists - compounds of Formula I: and Formula II: useful as antagonists of CGRP receptors and useful in the treatment or prevention of 11-13-2008
319. 20080280842 Fluorinated Pyrrolo[2,3-D]Pyrimidine Nucleosides for the Treatment of Rna-Dependent Rna Viral Infection 11-13-2008
320. 20080280836 Anti-hypercholesterolemic biaryl azetidinone compounds 11-13-2008
321. 20080280313 Coccidian Parasite Casein Kinase I as a Chemotherapeutic Target for Antiprotozoal Agents 11-13-2008
322. 20080275097 Non-nucleoside reverse transcriptase inhibitors 11-06-2008
323. 20080275069 Quinazoline Derivative - compound or its pharmaceutically-acceptable salt of formula wherein R 11-06-2008
324. 20080275004 N-Substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase 11-06-2008
325. 20080274498 Methods for producing modified glycoproteins 11-06-2008
326. 20080274476 Assay Method - There is disclosed a method for determining the activity of gamma-secretase in a text subject, using a biological sample from the subject 11-06-2008
327. 20080274452 Process For Large Scale Production Of Plasmid Dna By E.Coli Fermentation 11-06-2008
328. 20080274107 Tyrosine kinase inhibitors - compounds which inhibit regulate and/or modulate tyrosine kinase signal transduction 11-06-2008
329. 20080269302 Macrocyclic Tertiary Amine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease 10-30-2008
330. 20080269287 Substituted Pyridone Derivative - Compounds of a formula [wherein A represents formula R3 is a hydrogen lower alkyl et al 10-30-2008
331. 20080269279 Substituted furo[2,3-B] pyridine derivatives as cannabinoid-1 receptor modulators 10-30-2008
332. 20080269182 Method of treating cancers with SAHA and Pemetrexed 10-30-2008
333. 20080262051 Triazole derivatives which are SMO antagonists 10-23-2008
334. 20080262046 Amidopropoxyphenyl Orexin Receptor Antagonists 10-23-2008
335. 20080262035 Amide Derivatives as Inhibitors of Histone Deacetylase 10-23-2008
336. 20080261972 Cgrp Receptor Antagonists - Compounds of Formula 10-23-2008
337. 20080261944 Indole Derivatives as Antiviral Agents - indole compounds of the formula : wherein R 10-23-2008
338. 20080261938 Tetracyclic Indole Derivatives as Antiviral Agents 10-23-2008
339. 20080255216 Diaryltriazoles as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1 10-16-2008
340. 20080255072 Composition for Inhibition of Cathepsin K 10-16-2008
341. 20080254059 Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced Thereby 10-16-2008
342. 20080249146 Imidazole and Thioazole Derivatives as Antiviral Agents 10-09-2008
343. 20080249093 (3,4-Disubstituted)Propanoic Carboxylates as Sip (Edg) Receptor Agonists 10-09-2008
344. 20080248062 Papillomavirus vaccine compositions - pharmaceutical compositions comprising virus-like particles of HPV 10-09-2008
345. 20080248040 Nucleic Acid Molecules Encoding Novel Human Low-Voltage Activated Calcium Channel Proteins, Designed-Alpha 1I-1 and Alpha 1I-2, Encoded Proteins and Methods of Use Thereof 10-09-2008
346. 20080242722 Combination Therapy for Treating Cyclooxygenase-2 Mediated Diseases or Conditions in Patients at Risk of Thrombotic Cardiovascular Events 10-02-2008
347. 20080242657 Treatment of Tremor with Histamine H3 Inverse Agonists or Hist Amine H3 Antagonists 10-02-2008
348. 20080242643 Nitric Oxide Releasing Prodrugs of Diaryl-2-(5H)-Furanones as Cyclooxygenase-2 Inhibitors 10-02-2008
349. 20080242597 Antibiotic compounds - novel thiazolyl peptide antibiotics capable of treating serious bacterial infections in mammals 10-02-2008
350. 20080234281 Mitotic Kinesin Inhibitors - N-substituted benzylic aniline derivatives that are useful for treating cellular proliferative diseases 09-25-2008
351. 20080227786 Novel Crystalline Salts of a Dipeptidyl Peptidase-IV Inhibitor 09-18-2008
352. 20080227778 Isoquinolinone Potassium Channel Inhibitors 09-18-2008
353. 20080227758 Nitric Oxide Releasing Prodrugs of Diaryl-2-(5h)-Furanones as Cyclooxygenase-2 Inhibitors 09-18-2008
354. 20080226660 Optimized Expression of Hpv 58 L1 in Yeast 09-18-2008
355. 20080221198 Novel Crystalline Forms of Antidiabetic Compounds 09-11-2008
356. 20080221157 Amide Derivatives as Inhibitors of Histone Deacetylase 09-11-2008
357. 20080214594 Inhibitors Of Checkpoint Kinases - The instant invention provides for compounds which comprise fused pyrazoles that inhibit CHK1 activity 09-04-2008
358. 20080214522 Antiviral indoles - Compounds of the formula : wherein A, B, D, M, Ar, W, X, Y, Z and R 09-04-2008
359. 20080214511 Tricyclic Anilide Spirolactam Cgrp Receptor Antagonists 09-04-2008
360. 20080207693 Mitotic Kinesin Inhibitors - dihydropyrazole compounds that are useful for treating cellular proliferative diseases 08-28-2008
361. 20080207666 Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators 08-28-2008
362. 20080206786 Trace amine receptor 1 of the african green monkey 08-28-2008
363. 20080200513 Pyridine N-Oxides As Antiviral Agents - pyridinone derivatives of formula : wherein Z represents C 08-21-2008
364. 20080200494 Imidazopyridine Derivatives - The invention provides imidazopyridine derivatives represented by the general formula [I] [in which R 08-21-2008
365. 20080200376 Compositions and Methods For the Treatment Of Obesity and Sexual Dysfunction 08-21-2008
366. 20080199942 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast 08-21-2008
367. 20080199459 Mitotic Kinesin Inhibitors - dihydropyrrole compounds that are useful for treating cellular proliferative diseases 08-21-2008